Ozanimod

Status:

Do Not Prescribe (DNP), Red

Decision Date:

January 2021

Comments

Do Not Prescribe: NICE TA706 - Ozanimod for treating relapsing–remitting multiple sclerosis (Decision date - July 2021)

RED: NICE TA828 - Ozanimod for treating moderately to severely active ulcerative colitis. ICB commissioned. (Decision date - November 2022)

search again